Table 1 Demograpic and baseline characteristics.

From: Mid-term safety and effectiveness of macular peeling one month after intravitreal dexamethasone implant for tractional diabetic macular edema

 

Group A (n = 11)

Group B (n = 10)

p

Age, years

71,9 ± 5,1

73,2 ± 8,1

0.7

Sex

Male

5 (45.4)

4 (40)

 

Female

6 (54.6)

6 (60)

1*

Type 2 DM

10 (91)

9 (90)

 

Type 1 DM

1 (9)

1 (10)

1*

Glycated hemoglobin (%)

7 ± 0,5

7 ± 0,8

0.9

Years from diagnosis of diabetes

16 ± 5,3

17,8 ± 6,5

0.3

BVCA, logMAR

0,82 ± 0,4

0,76 ± 0,2

0.8

CRT, microns

419,1 ± 81,5

408,5 ± 55,4

0.8

IOP, mmHg

16,3 ± 1,7

15,6 ± 1,7

0.5

  1. DM Diabetes mellitus, BCVA Best corrected visual acuity, CRT Central retinal thickness, IOP Intraocular pressure. Unless otherwise indicated, values are mean ± SD or no. (%). p, Mann–whitney U test, *, Fisher’s exact test.
Back to article page